Here, we examined the contribution of CD8+ T cells to the anti-metastatic effects of p38 blockade using a well-recognized mTNBC model of 4T1 mammary carcinoma cells in syngeneic BALB/c mice [23–25]. This evidence concerns the gene CD8A and breast carcinoma.